Vitamin D3 + K2: The Combination Your Bones and Heart Actually Need

The Vitamin D Crisis is Real

Vitamin D deficiency is one of the most prevalent nutritional problems in the developed world. Depending on the threshold used, anywhere from 42% to 67% of Americans have suboptimal vitamin D status. The situation is worse in northern latitudes, among people with darker skin tones, those who work indoors, and the elderly.

The consequences extend far beyond bone health. Low vitamin D is associated with increased risk of:

• Autoimmune diseases (multiple sclerosis, type 1 diabetes, rheumatoid arthritis)
• Cardiovascular disease
• Depression and mood disorders
• Respiratory infections (including COVID-19 severity)
• Certain cancers (colorectal, breast, prostate)
• Insulin resistance and type 2 diabetes

But there's a problem with blanket high-dose D3 supplementation that most people don't hear about.

Why High-Dose D3 Needs K2

Vitamin D3 dramatically increases calcium absorption from the gut. This is its primary mechanism for building bone density. But absorbed calcium needs to be directed to the right places — bones and teeth — not soft tissues.

This is where vitamin K2 comes in.

K2 activates two critical proteins:

1. Osteocalcin — Carries calcium into bone matrix. Without K2, osteocalcin remains inactive (undercarboxylated) and can't bind calcium to bone
2. Matrix Gla Protein (MGP) — The most potent known inhibitor of vascular calcification. Without K2 activation, calcium deposits in arterial walls

The Rotterdam Study (Geleijnse et al., 2004) [1] followed 4,807 participants and found high dietary K2 intake was associated with a 57% reduction in CHD mortality and 52% reduction in severe aortic calcification. The highest K2 intake tertile also showed a 26% reduction in all-cause mortality compared to the lowest tertile (RR=0.74).

Without adequate K2, supplementing high-dose D3 may actually accelerate arterial calcification — directing calcium into your arteries rather than your bones.

Optimal Vitamin D Levels

The debate about optimal serum 25(OH)D levels continues, but current evidence supports:

Most people with deficiency need 2,000-5,000 IU/day to reach optimal levels. Those with malabsorption conditions (IBD, celiac disease) or obesity may need considerably more.

Key point: Never supplement vitamin D without testing first. 25(OH)D testing is inexpensive and available at any lab. Supplementing without knowing your baseline is inefficient at best and potentially problematic at high doses.

Vitamin K2 Forms: MK-4 vs MK-7

Vitamin K2 exists in multiple forms, the two most studied being:

MK-4 (menaquinone-4)

• Synthetic; found in some animal products
• Half-life: ~1 hour
• Requires multiple daily doses (45 mg/day in osteoporosis trials)
• Best studied for bone outcomes at high doses

MK-7 (menaquinone-7)

• Natural; derived from natto (fermented soybean)
• Half-life: 72 hours (allows once-daily dosing)
• Effective at much lower doses (100-200 mcg/day)
• Better evidence for cardiovascular protection
• The preferred form for daily supplementation

MK-7 at 100-200 mcg/day is the optimal form for co-supplementation with D3 and is used in ONES AI formulas.

Recommended Dosing Protocol

Standard Protocol (low-normal vitamin D)

• D3: 2,000-3,000 IU/day
• K2 (MK-7): 100-200 mcg/day

Deficiency Correction (serum 25(OH)D <30 ng/mL)

• D3: 4,000-5,000 IU/day
• K2 (MK-7): 200 mcg/day
• Retest after 12 weeks

Maintenance (optimal level achieved)

• D3: 1,000-2,000 IU/day
• K2 (MK-7): 100 mcg/day

Timing: Both D3 and K2 are fat-soluble — take with your fattiest meal of the day for optimal absorption.

Magnesium note: Vitamin D metabolism requires magnesium as a cofactor. If you're supplementing both without adequate magnesium, D3 conversion to its active form (calcitriol) may be impaired. The ONES AI formula approach always considers this triad: D3 + K2 + Mg.

Who Needs This Combination Most

The D3+K2 combination is particularly critical for:

1. Adults over 50 — Bone density and cardiovascular calcification risk both increase with age
2. Postmenopausal women — Dramatically elevated osteoporosis risk
3. People on anticoagulants (warfarin/Coumadin) — Warfarin works by inhibiting vitamin K; discuss with your physician before supplementing K2
4. Anyone with known low vitamin D — Maximize the D3 benefit while protecting cardiovascular tissue
5. People with statin use — Statins may deplete vitamin K2 (CoQ10 and K2 share the same biosynthetic pathway)

Contraindications and Cautions

• Warfarin users: K2 can interfere with anticoagulation — consult your physician
• Hypercalcemia: D3 increases calcium absorption; avoid in those with elevated serum calcium
• Primary hyperparathyroidism: Avoid high-dose D3
• Sarcoidosis and granulomatous diseases: These can cause hypersensitivity to vitamin D

How ONES AI Personalizes Your Formula

Every ONES AI formula is built around your data — not population averages, generic recommendations, or marketing copy.

When your lab results, health history, and symptom picture suggest a need in the area discussed above, our AI health practitioner will:

• Explain which compounds the clinical evidence supports for your situation
• Select ingredients and doses from our curated catalog of 70+ clinical-grade ingredients
• Build a formula that fits your daily capsule budget and avoids interactions with your current medications or supplements
• Provide a clear rationale for every ingredient included — and every ingredient left out

No guessing. No one-size-fits-all blends. A formula that reflects your actual physiology.

Start your personalized assessment →

These statements have not been evaluated by the Food and Drug Administration. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement regimen.

---

References

1. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study." Journal of Nutrition. 2004 Nov;134(11):3100–5. PMID: 15514282

→ Note: This population study (n=4,807) found high dietary K2 intake associated with 57% reduction in CHD mortality (RR=0.43) and 52% reduction in severe aortic calcification (OR=0.48), and 26% reduction in all-cause mortality (RR=0.74), compared to the lowest intake tertile.

1. Holick MF. "Vitamin D deficiency." New England Journal of Medicine. 2007;357(3):266–81. PMID: 17634462

1. Theuwissen E, Smit E, Vermeer C. "The role of vitamin K in soft-tissue calcification." Advances in Nutrition. 2012;3(2):166–73. PMID: 22516724

Note: All doses and outcomes stated in this article reflect the specific trials or observational studies cited. Individual responses vary. This is not medical advice.